DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
He K, Luettgen JM, Zhang D. , et al.
Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor.
Eur J Drug Metab Pharmacokinet 2011;
36 (03) 129-139
We do not assume any responsibility for the contents of the web pages of other providers.